Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: Modulation of interferon-regulated gene expression by Rel/nuclear factor κB

Journal of Experimental Medicine

Volumn 191, Issue 8, 2000, Pages 1281-1291

  Grumont, Raelene J ^a   Gerondakis, Steve ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Interferon; IRF 4; Lymphocytes; Rel NF KB; Transcription

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE REPRESSION; GENE TARGETING; IMMUNOMODULATION; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; DNA PRIMERS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; INTERFERONS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGENS; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-REL; TRANSCRIPTION FACTORS;

EID: 0034678445     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.8.1281     Document Type: Article

References (51)

1. Crabtree, G.R. 1989. Contingent genetic regulatory events in T lymphocyte activation. Science. 243:355-361.
2. Gerondakis, S., R. Grumont, I. Rourke, and M. Grossmann. 1998. The regulation and roles of Rel/NF-κB transcription factors during lymphocyte activation. Curr. Opin. Immunol. 10:353-359.
3. Baeuerle, P.A., and T. Henkel. 1994. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12:141-179.
4. Baldwin, A.S., Jr. 1996. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14: 649-683.
5. Finco, T.S., and A.S. Baldwin. 1995. Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis. Immunity. 3:263-272.
6. Verma, I.M., J.K. Stevenson, E.M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.
7. Kontgen, F., R.J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit detects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1965-1977.
8. Gerondakis, S., A. Strasser, D. Metcalf, G. Grigoriadis, J.Y. Scheerlinck, and R.J. Grumont. 1996. Rel-deficient T cells exhibit detects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor. Proc. Natl. Acad. Sci. USA. 93:3405-3409.
9. Grigoriadis, G., Y. Zhan, R.J. Grumont, D. Metcalf, E. Handman, C. Cheers, and S. Gerondakis. 1996. The Rel subunit of NF-kappaB-like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Rel in different macrophage populations. EMBO (Eur. Mol. Biol. Organ.) J. 15:7099-7107.
10. Grumont, R.J., I.J. Rourke, L.A. O'Reilly, A. Strasser, K. Miyake, W. Sha, and S. Gerondakis. 1998. B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J. Exp. Med. 187:663-674.
11. Grumont, R.J., I.J. Rourke, and S. Gerondakis. 1999. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 13:400-411.
12. Matsuyama, T., A. Grossman, H.W. Mittrucker, D.P. Siderovski, F. Kiefer, T. Kawakami, C.D. Richardson, T. Taniguchi, S.K. Yoshinaga, and T.W. Mak. 1995. Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res. 23:2127-2136.
13. Grumont, R.J., and S. Gerondakis. 1994. The subunit composition of NF-kappa B complexes changes during B-cell development. Cell Growth Differ. 5:1321-1331.
14. Mittrucker, H.W., T. Matsuyama, A. Grossman, T.M. Kundig, J. Potter, A. Shahinian, A. Wakeham, B. Patterson, P.S. Ohashi, and T.W. Mak. 1997. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science. 275:540-543.
15. Iida, S., P.H. Rao, M. Butler, P. Corradini, M. Boccadoro, B. Klein, R.S. Chaganti, and R. Dalla-Favera. 1997. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nat. Genet. 17:226-230.
16. Nguyen, H., J. Hiscott, and P.M. Pitha. 1997. The growing family of interferon regulatory factors. Cytokine Growth Factor Rev: 8:293-312.
17. Tanaka, N., T. Kawakami, and T. Taniguchi. 1993. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol. Cell. Biol. 13:4531-4538.
18. Taniguchi, T., M.S. Lamphier, and N. Tanaka. 1997. IRF-1: the transcription factor linking the interferon response and oncogenesis. Biochim. Biophys. Acta. 1333:M9-M17.
19. Fujita, T., Y. Kimura, M. Miyamoto, E.L. Barsoumian, and T. Taniguchi. 1989. Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1. Nature. 337:270-272.
20. Harada, H., T. Fujita, M. Miyamoto, Y. Kimura, M. Maruyama, A. Furia, T. Miyata, and T. Taniguchi. 1989. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell. 58:729-739.
21. Sha, W.C., H.C. Lion, E.I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell. 80: 321-330.
22. Luckow, B., and G. Schutz. 1987. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15:5490.
23. Ho, S.N., H.D. Hunt, R.M. Horton, J.K. Pullen, and L.R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene. 77:51-59.
24. Miyake, K., Y. Yamashita, Y. Hitoshi, K. Takatsu, and M. Kimoto. 1994. Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells. J. Exp. Med. 180:1217-1224.
25. Grumont, R.J., I.B. Richardson, C. Gaff, and S. Gerondakis. 1993. rel/NF-kappa B nuclear complexes that bind κB sites in the murine c-rel promoter are required for constitutive c-rel transcription in B-cells. Cell Growth Differ. 4:731-743.
26. Bohnlein, E., M. Siekevitz, D.W. Ballard, J.W. Lowenthal, L. Rimsky, H. Bogerd, J. Hoffman, Y. Wano, B.R. Franza, and W.C. Greene. 1989. Stimulation of the human immunodeficiency virus type 1 enhancer by the human T-cell leukemia virus type I tax gene product involves the action of inducible cellular proteins. J. Virol. 63:1578-1586.
27. Whiteside, S.T., M.K. Ernst, O. LeBail, C. Laurent-Winter, N. Rice, and A. Israel. 1995. N- and C-terminal sequences control degradation of MAD3/I kappa B alpha in response to inducers of NF-kappa B activity. Mol. Cell. Biol. 15:5339-5345.
28. Pear, W.S., G.P. Nolan, M.L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA. 90:8392-8396.
29. Eisenbeis, C.F., H. Singh, and U. Storb. 1995. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev. 9:1377-1387.
30. Piechaczyk, M., J.M. Blanchard, L. Marty, C. Dani, F. Panabieres, S. El Sabouty, P. Fort, and P. Jeanteur. 1984. Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissues. Nucleic Acids Res. 12:6951-6963.
31. Ichii, Y., R. Fukunaga, S. Shiojiri, and Y. Sokawa. 1986. Mouse 2-5A synthetase cDNA: nucleotide sequence and comparison to human 2-5A synthetase. Nucleic Acids Res. 14: 10117.
32. Tokunaga, K., H. Taniguchi, K. Yoda, M. Shimizu, and S. Sakiyama. 1986. Nucleotide sequence of a full-length cDNA for mouse cytoskeletal beta-actin mRNA. Nucleic Acids Res. 14:2829.
33. Yamagata, T., J. Nishida, S. Tanaka, R. Sakai, K. Mitani, M. Yoshida, T. Taniguchi, Y. Yazaki, and H. Hirai. 1996. A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol. Cell. Biol. 16:1283-1294.
34. Brass, A.L., E. Kehrli, C.F. Eisenbeis, U. Storb, and H. Singh. 1996. Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1. Genes Dev. 10: 2335-2347.
35. Lindahl-Magnusson, P., P. Leary, and I. Gresser. 1972. Interferon inhibits DNA synthesis induced in mouse lymphocyte suspensions by phytohaemagglutinin or by allogeneic cells. Nature New Biol. 237:120-121.
36. Belardelli, F., and I. Gresser. 1996. The neglected role of type 1 interferon in the T-cell response: implications for its clinical use. Immunol. Today. 17:369-372.
37. Williams, B.R. 1991. Transcriptional regulation of interferon-stimulated genes. Eur. J. Biochem. 200:1-11.
38. Miyamoto, M., T. Fujita, Y. Kimura, M. Maruyama, H. Harada, Y. Sudo, T. Miyata, and T. Taniguchi. 1988. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell. 54:903-913.
39. Smith, M.R., and W.C. Greene. 1991. Molecular biology of the type 1 human T-cell leukemia virus (HTLV-1) and adult T-cell leukemia. J. Clin. Invest. 87:761-766.
40. Yoshida, M., T. Suzuki, J. Fujisawa, and H. Hirai. 1995. HTLV-1 oncoprotein tax and cellular transcription factors. Curr. Top. Microbiol. Immunol. 193:79-89.
41. Urban, M.B., R. Schreck, and P.A. Baeuerle. 1991. NF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunit. EMBO (Eur. Mol. Biol. Organ.) J. 10:1817-1825.
42. Hansen, S.K., C. Nerlov, U. Zabel, P. Verde, M. Johnsen, P.A. Baeuerle, and F. Blasi. 1992. A novel complex between the p65 subunit of NF-kappa B and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene. EMBO (Eur. Mol. Biol. Organ.) J. 11: 205-213.
43. Kunsch, C., S.M. Ruben, and C.A. Rosen. 1992. Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation. Mol. Cell. Biol. 12:4412-4421.
44. Lenardo, M.J., C.M. Fan, T. Maniatis, and D. Baltimore. 1989. The involvement of NF-kappa B in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell. 57:287-294.
45. Bovolenta, C., P.H. Driggers, M.S. Marks, J.A. Medin, A.D. Politis, S.N. Vogel, D.E. Levy, K. Sakaguchi, E. Appella, J.E. Coligan, and et al. 1994. Molecular interactions between interferon consensus sequence binding protein and members of the interteron regulatory factor family. Proc. Natl. Acad. Sci. USA. 91:5046-5050.
46. Varmus, H., and R. Swanstrom. 1982. Replication of retroviruses. In RNA Tumor Viruses. 2nd ed. R. Weiss, N. Teich, H. Varmus, and J. Coffin, editors. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 369-512.
47. Inoue, J., L.D. Kerr, L.J. Ransone, E. Bengal, T. Hunter, and I.M. Verma. 1991. c-rel activates but v-rel suppresses transcription from kappa B sites. Proc. Natl. Acad. Sci. USA. 88: 3715-3719.
48. Gilmore, T.D. 1992. Role of rel family genes in normal and malignant lymphoid cell growth. Cancer Surv. 15:69-87.
49. Lengyel, P. 1982. Biochemistry of interferons and their actions. Annu. Rev. Biochem. 51:251-282.
50. Chebath, J., P. Benech, A. Hovanessian, J. Galabru, and M. Revel. 1987. Four different forms of interferon-induced 2′,5′-oligo(A) synthetase identified by immunoblotting in human cells. J. Biol. Chem. 262:3852-3857.
51. Rysiecki, G., D.R. Gewert, and B.R. Williams. 1989. Constitutive expression of a 2′,5′-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression. J. Interferon Res. 9:649-657.